Exemestane 25 mg/tab – US Stock
$25.86
Exemestane 25 mg/tab is an oral tablet formulation containing exemestane, a steroidal aromatase inhibitor. Each tablet contains 25 mg of active ingredient, with 30 tablets per pack and a stated active half-life of approximately 24 hours. Manufactured by Hilma Biocare and listed as US Stock.
Exemestane 25 mg/tab – US Stock
Exemestane 25 mg/tab from Hilma Biocare is an oral tablet formulation containing exemestane, a steroidal aromatase inhibitor. Each tablet contains 25 mg of active ingredient, and the product is supplied in a 30-tablet pack.
Product Overview
Exemestane is a steroidal aromatase inhibitor structurally related to androstenedione. The supplied product description identifies exemestane as an anti-estrogenic compound used in medical settings and describes its activity in relation to estrogen production.
The product specifications identify an active half-life of approximately 24 hours. Exemestane is supplied as an oral tablet and is specified as having no water retention or aromatization.
Active Ingredient
The active ingredient is Exemestane, a steroidal aromatase inhibitor.
Dosage Form and Strength
Exemestane is supplied as an oral tablet containing 25 mg of active ingredient per tablet.
Product Characteristics
According to the supplied specifications, Exemestane has the following characteristics:
- Steroidal aromatase inhibitor
- Oral tablet formulation
- 25 mg exemestane per tablet
- Approximately 24-hour active half-life
- 30 tablets per pack
- No water retention listed
- No aromatization listed
Product Specifications
| Specification | Details |
|---|---|
| Brand | Hilma Biocare |
| Active Ingredient | Exemestane |
| Group | Aromatase inhibitor |
| Form | Oral tablet |
| Strength | 25 mg per tablet |
| Active Half-Life | Approximately 24 hours |
| Pack Size | 30 tablets |
| Water Retention | No, according to supplied specifications |
| Aromatization | No, according to supplied specifications |
| Stock | US Stock |
Product Characteristics
Exemestane is a steroidal aromatase inhibitor that acts on the aromatase pathway involved in estrogen production. The supplied description also notes that exemestane does not have progestogenic or estrogenic activity and does not interfere with cortisol or aldosterone biosynthesis in the adrenal glands.
The source material discusses exemestane in connection with estrogen management and its use in bodybuilding contexts. These descriptions should not be interpreted as recommendations for steroid cycles, post-cycle therapy, or self-treatment.
Reported Side Effects
The supplied product information identifies several possible adverse effects, including:
- Skin rash
- Nausea
- Abdominal pain
- Fatigue
- Dizziness
- Headache
- Insomnia
- Emotional distress
Because exemestane significantly affects estrogen metabolism, its risks and suitability can vary between individuals. Appropriate medical guidance and relevant clinical monitoring should be considered.
Important Information
Exemestane is a pharmacologically active aromatase inhibitor. The information on this page is provided for product identification and factual specification purposes only and does not constitute personalized medical advice.
No dosing recommendations, treatment protocols, steroid-cycle instructions, post-cycle therapy protocols, or stacking regimens are provided. The supplied source discusses use alongside other compounds; these combinations are not presented here as recommendations.
About Hilma Biocare USA
Exemestane 25 mg/tab is part of the Hilma Biocare product range. Each tablet contains 25 mg of exemestane, and the product is supplied in a 30-tablet pack with a stated active half-life of approximately 24 hours, listed as US Stock.

Reviews
There are no reviews yet.